Evidence-based prescribing of statins: A developing world perspective
2006

Evidence-Based Prescribing of Statins: A Developing World Perspective

Sample size: 90056 publication Evidence: moderate

Author Information

Author(s): H. T. Ong

Primary Institution: H. T. Ong Heart Clinic, Penang, Malaysia

Hypothesis

How should trial evidence on statins be applied to a resource-poor setting?

Conclusion

Statin therapy can be cost-effective for high-risk patients, but financial constraints in developing countries complicate its widespread use.

Supporting Evidence

  • Statin therapy reduces coronary events in patients with or without prior cardiovascular disease.
  • A meta-analysis involving 90,056 patients found that statin treatment reduces strokes and total mortality.
  • Statins should be prescribed based on cardiovascular risk rather than solely on lipid levels.
  • Ethnic differences in response to statins suggest that treatment may need to be tailored to specific populations.
  • Statin therapy is cost-effective for high-risk patients, but affordability is a major issue in developing countries.

Takeaway

Statins help prevent heart problems, but they're really expensive, especially in poorer countries, so doctors need to be careful about who gets them.

Methodology

The paper reviews landmark clinical trials and meta-analyses to assess the effectiveness and cost-effectiveness of statins in various populations.

Potential Biases

Ethnic minorities were underrepresented in landmark trials, which may affect the applicability of findings.

Limitations

The trials primarily involved Western populations, which may not accurately represent responses in developing countries.

Participant Demographics

The study discusses various ethnic groups, including Asians and eastern Europeans, but does not provide specific demographics.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030050

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication